NorthWest Biotherapeutics Inc (NWBO)

[photonic5]

We don’t really have an “opponent”. What we have is a security that may be extremely misvalued, depending on the results of a late P3 clinical trial and the potential to turn the results of that trial into a marketable and profitable product line.

Any “opponent” would be a financial institution that might be using illegal methods to artificially manipulate the price of a publicly traded security, including ours. I believe yours and divers conversation spoke to the fact that it probably happens with great frequency on Wall St. Whether or not it is happening with this security and whether or not such activity will be unearthed remains to be seen.